(Q41581740)

4 October 2017

1 reference

title

Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics (English)

1 reference

4 October 2017

0 references

1 reference

1 reference

schizophrenic psychology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9278188

13 November 2024

author name string

S. E. Bachus

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9278188

13 November 2024

T. M. Hyde

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9278188

13 November 2024

M. M. Herman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9278188

13 November 2024

M. F. Egan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9278188

13 November 2024

J. E. Kleinman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9278188

13 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9278188

13 November 2024

publication date

1 March 1997

1 reference

4 October 2017

March 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9278188

full work available at URL

13 November 2024

https://mdsoar.org/bitstream/11603/17884/1/1-s2.0-S0022395696000416-main.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9278188

https://api.elsevier.com/content/article/PII:S0022395696000416?httpAccept=text/xml

13 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

https://api.elsevier.com/content/article/PII:S0022395696000416?httpAccept=text/plain

13 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

Journal of Psychiatric Research

13 November 2024

published in

1 reference

4 October 2017

volume

31

1 reference

4 October 2017

issue

2

1 reference

4 October 2017

page(s)

233-256

1 reference

Sources of neostriatal cholecystokinin in the cat.

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cholecystokinin-induced protection of cultured cortical neurons against glutamate neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Ceruletide: A New Drug for the Treatment of Schizophrenic Patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

A double-blind study with ceruletide in chronic schizophrenic patients: biochemical and clinical results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

The hippocampus and parahippocampus in schizophrenia, suicide, and control brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

The duality of the cingulate gyrus in monkey. Neuroanatomical study and functional hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Increased Density of Glutamate-immunoreactive Vertical Processes in Superficial Laminae in Cingulate Cortex of Schizophrenic Brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Commissural connections of the hippocampal region in the rat, with special reference to their mode of termination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

[Neuropathology of schizophrenias]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cortical neurons expressing the cholecystokinin gene in the rat: distribution in the adult brain, ontogeny, and some of their projections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Quantitative shape analysis of the temporal and prefrontal lobes of schizophrenic patients: a magnetic resonance image study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Comparative distribution of mRNAs for glutamic acid decarboxylase, tyrosine hydroxylase, and tachykinins in the basal ganglia: an in situ hybridization study in the rodent brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Proglumide: selective antagonism of excitatory effects of cholecystokinin in central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Excitatory amino acid projections to the nucleus accumbens septi in the rat: a retrograde transport study utilizing D[3H]aspartate and [3H]GABA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Transient cells of the developing mammalian telencephalon are peptide-immunoreactive neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

White matter reduction in the parahippocampal gyrus of patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Tyrosine hydroxylase and cholecystokinin mRNA levels in the substantia nigra, ventral tegmental area, and locus ceruleus are unaffected by acute and chronic haloperidol administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cholecystokinin-octapeptide enhances synaptic activity in neurons cultured from rat cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Perinatal complications and reduced size of brain limbic structures in familial schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cholecystokinin octa- and tetrapeptide degradation by synaptic membranes. I. Evidence for competition with enkephalins for in vitro common degradation pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Amino acid neurotransmitters and their pathways in the mammalian central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cell loss in the hippocampus of schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Limbic pathology in schizophrenia: the entorhinal region--a morphometric study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Reduced high affinity cholecystokinin binding in hippocampus and frontal cortex of schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Reduced cholecystokinin levels in the limbic lobe in schizophrenia. A marker for pathology underlying the defect state?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

The performance of young schizophrenics and young normals on the Wisconsin Card Sorting Test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Localization of enkephalin and cholecystokinin immunoreactivities in the perforant path terminal fields of the rat hippocampal formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cholecystokinin octapeptide levels in rat brain are changed after subchronic neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

The left medial temporal region and schizophrenia. A PET study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Dual pathways connecting the dorsolateral prefrontal cortex with the hippocampal formation and parahippocampal cortex in the rhesus monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cholecystokinin in hippocampal pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Failure of chronic haloperidol treatment to alter levels of cholecystokinin in the rat brain striatum and olfactory tuberclenucleus accumbens area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

[3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Localization of cholecystokinin receptors on neuronal elements in rat caudate nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Dopamine Nerve Terminals in the Rat Limbic Cortex: Aspects of the Dopamine Hypothesis of Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

The Effects of Ceruletide in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

The brain in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

The entorhinal cortex of the monkey: II. Cortical afferents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

The entorhinal cortex of the monkey: III. Subcortical afferents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Prenatal developmental disturbances in the limbic allocortex in schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Entorhinal-hippocampal connections: a speculative view of their function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

SPECT analysis of regional cerebral blood flow changes in patients with schizophrenia during the Wisconsin Card Sorting Test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Different modifications of the dopamine metabolism in the core and shell parts of the nucleus accumbens following CCK-A receptor stimulation in the shell region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Effects of dopamine agonists on excitatory inputs to nucleus accumbens neurons from the amygdala: modulatory actions of cholecystokinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

A high-dose, double-blind study of ceruletide in the treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

A glutamatergic corticostriatal path?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Corpus callosum lesions increase cholecystokinin concentrations in cortical areas with homeotopic connections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Origin of the cholecystokinin-containing fibers in the rat caudatoputamen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

The calibration of 35S or 32P with 14C-labeled brain paste or 14C-plastic standards for quantitative autoradiography using LKB Ultrofilm or Amersham Hyperfilm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cholecystokinin-octapeptide in chronic schizophrenia: a double-blind placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cholecystokinin appears to have antipsychotic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

An experimental study of the ventral striatum of the golden hamster. I. Neuronal connections of the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cholecystokinin- and dopamine-containing mesencephalic neurons provide distinct projections to monkey prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Postnatal development of the cholecystokinin innervation of monkey prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

G proteins (Gi, Go) in the medial temporal lobe in schizophrenia: preliminary report of a neurochemical correlate of structural change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Glutamate receptor dysfunction and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Does cholecystokinin colocalize with dopamine in the human substantia nigra?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Neuropeptides in Alzheimer's disease, depression and schizophrenia. A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Effects of short- and long-term haloperidol administration and withdrawal on regional brain cholecystokinin and neurotensin concentrations in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Hypertrophy and Increased Gene Expression of Neurons Containing Neurokinin-B and Substance-P Messenger Ribonucleic Acids in the Hypothalami of Postmenopausal Women*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Hippocampal efferents reach widespread areas of cerebral cortex and amygdala in the rhesus monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

A comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey: I. Convergence in the entorhinal, prorhinal, and perirhinal cortices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Common cortical and subcortical targets of the dorsolateral prefrontal and posterior parietal cortices in the rhesus monkey: evidence for a distributed neural network subserving spatially guided behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rat mesencephalon: peptide/monoamine coexistence studies using in situ hybridization combined with immunocytochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Evidence of glutamatergic deficiency in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cellular localization of tyrosine hydroxylase mRNA and cholecystokinin mRNA-containing cells in the ventral mesencephalon of the common marmoset: effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin- immunoreactive material

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Entorhinal efferents reach the caudato-putamen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Glutamic acid and excitatory nerve endings: reduction of glutamic acid uptake after axotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Uptake of [3H]Glutamic acid in excitatory nerve endings: light and electronmicroscopic observations in the hippocampal formation of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Distinct properties of cholecystokinin-8 and mixed dopamine-cholecystokinin-8 neurons innervating the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Opposite effects of sulfated cholecystokinin on DA-sensitive adenylate cyclase in two areas of the rat nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Anatomical evidence for direct projections from the entorhinal area to the entire cortical mantle in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Mechanisms of cholecystokinin-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Uptake of D-aspartate and L-glutamate in excitatory axon terminals in hippocampus: autoradiographic and biochemical comparison with gamma-aminobutyrate and other amino acids in normal rats and in rats with lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cholecystokinin-immunoreactive boutons in synaptic contact with hippocampal pyramidal neurons that project to the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. III. Efferent connections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Ceruletide resembles antipsychotics in rats and schizophrenic patients. Preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Animal and clinical research on neuropeptides and schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Pharmacological and mechanistic studies of cholecystokinin-facilitated [3H]dopamine efflux from rat nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Human cingulate cortex: surface features, flat maps, and cytoarchitecture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

The effects of surgical and chemical lesions on neurotransmitter candidates in the nucleus accumbens of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Does cholecystokinin potentiate dopamine action in the nucleus accumbens?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Electrophysiological responses of neurones in the nucleus accumbens to hippocampal stimulation and the attenuation of the excitatory responses by the mesolimbic dopaminergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Cortico-striate projections in the rhesus monkey: The organization of certain cortico-caudate connections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Electrophysiological evidence of modulatory interaction between dopamine and cholecystokinin in the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

Reduced GABA uptake sites in the temporal lobe in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900041-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Is cholecystokinin therapeutic in chronic schizophrenia?

21

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist

13 November 2024

25

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin

13 November 2024

36

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

Neonatal 6-OHDA lesions upregulate adult expression of tyrosine hydroxylase mRNA

13 November 2024

52

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

Neuropeptide-containing neurons of the cerebral cortex are also GABAergic

13 November 2024

62

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

13 November 2024

66

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

Clinical evaluation of ceruletide in schizophrenia: a multi-institutional cooperative double-blind controlled study

13 November 2024

71

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

Is cholecystokinin an antipsychotic agent?

13 November 2024

73

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide

13 November 2024

76

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

Distribution of CCK binding sites in the human hippocampal formation and their alteration in schizophrenia: a post-mortem autoradiographic study

13 November 2024

79

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

Role and localization of serotonin2 (S2)-receptor-binding sites: effects of neuronal lesions

13 November 2024

87

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

No evidence of antipsychotic effect of caerulein in schizophrenic patients free of neuroleptics: a double-blind cross-over study

13 November 2024

90

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

Analysis of expression of cholecystokinin in dopamine cells in the ventral mesencephalon of several species and in humans with schizophrenia

13 November 2024

120

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

Cholecystokinin: a neuropeptide in the treatment of schizophrenia

13 November 2024

140

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

Convergence of hippocampal and dopaminergic input onto identified neurons in the nucleus accumbens of the rat

13 November 2024

145

1 reference

https://api.crossref.org/works/10.1016/S0022-3956(96)00041-6

13 November 2024

Identifiers

1 reference

4 October 2017

1 reference